{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:51:10Z","timestamp":1786996270696,"version":"build-2736575974"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Developmental Disabilities"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.ridd.2013.12.004","type":"journal-article","created":{"date-parts":[[2014,1,7]],"date-time":"2014-01-07T02:00:20Z","timestamp":1389060020000},"page":"711-725","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["The effectiveness of aripiprazole in the management of problem behaviour in people with intellectual disabilities, developmental disabilities and\/or autistic spectrum disorder \u2013 A systematic review"],"prefix":"10.1016","volume":"35","author":[{"given":"Shoumitro","family":"Deb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baldeep K.","family":"Farmah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5645-4592","authenticated-orcid":false,"given":"Ebrahim","family":"Arshad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Deb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meera","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma L.","family":"Unwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ridd.2013.12.004_bib0005","first-page":"283","article-title":"The aberrant behavior checklist-community: Factor validity and effect of subject variables for adults in group homes","volume":"100","author":"Aman","year":"1995","journal-title":"American Journal of Mental Retardation"},{"key":"10.1016\/j.ridd.2013.12.004_bib0010","series-title":"Challenging behaviour: A unified approach (Clinical and service guidelines for supporting people with learning disabilities who are at risk of receiving abusive or restrictive practices)","year":"2007"},{"key":"10.1016\/j.ridd.2013.12.004_bib0225","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1192\/bjp.154.5.672","article-title":"A rating scale for drug-induced akathisia","volume":"154","author":"Barnes","year":"1989","journal-title":"British Journal of Psychiatry"},{"issue":"S1","key":"10.1016\/j.ridd.2013.12.004_bib0015","first-page":"S7","article-title":"Use of aripiprazole in children and adolescents: Case reports","volume":"20","author":"Basgul","year":"2011","journal-title":"Child and Adolescent Psychiatry"},{"key":"10.1016\/j.ridd.2013.12.004_bib0020","series-title":"Oxford textbook of epilepsy and epileptic seizures: Oxford textbooks in clinical neurology","first-page":"195","article-title":"Epilepsy in learning disability","author":"Berney","year":"2012"},{"key":"10.1016\/j.ridd.2013.12.004_bib0025","series-title":"Handbook of mental retardation and developmental disabilities","first-page":"81","article-title":"Epilepsy in people with mental retardation","author":"Deb","year":"2007"},{"key":"10.1016\/j.ridd.2013.12.004_bib0030","series-title":"Handbook of psychopathology in intellectual disability: Research, practice, and policy, autism and child psychopathology series","first-page":"307","article-title":"Psychopharmacology","author":"Deb","year":"2013"},{"key":"10.1016\/j.ridd.2013.12.004_bib0035","series-title":"Using medication to manage behaviour problems among adults with a learning disability: Quick reference guide (QRG)","isbn-type":"print","author":"Deb","year":"2006","ISBN":"https:\/\/id.crossref.org\/isbn\/0855370947"},{"key":"10.1016\/j.ridd.2013.12.004_bib0040","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/hup.470090405","article-title":"The use of psychotropic medication in people with learning disability: Towards rational prescribing","volume":"9","author":"Deb","year":"1994","journal-title":"Human Psychopharmacology"},{"issue":"3","key":"10.1016\/j.ridd.2013.12.004_bib0045","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/j.2051-5545.2009.tb00248.x","article-title":"International guide to prescribing psychotropic medication for the management of problem behaviours in adults with intellectual disabilities","volume":"8","author":"Deb","year":"2009","journal-title":"World Psychiatry"},{"issue":"10","key":"10.1016\/j.ridd.2013.12.004_bib0050","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1365-2788.2007.00950.x","article-title":"The effectiveness of antipsychotic medication in the management of behaviour problems in adults with intellectual disabilities","volume":"51","author":"Deb","year":"2007","journal-title":"Journal of Intellectual Disability Research"},{"issue":"6","key":"10.1016\/j.ridd.2013.12.004_bib0055","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/jech.52.6.377","article-title":"The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions","volume":"52","author":"Downs","year":"1998","journal-title":"Journal of Epidemiology and Community Health"},{"issue":"1","key":"10.1016\/j.ridd.2013.12.004_bib0060","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2147\/nedt.2007.3.1.173","article-title":"Aripiprazole treatment of Asperger's syndrome in the acute psychiatric setting: Case report","volume":"3","author":"Dratcu","year":"2007","journal-title":"Neuropsychiatric Disease and Treatment"},{"key":"10.1016\/j.ridd.2013.12.004_bib0065","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1192\/apt.7.1.43","article-title":"Systematic management approach to pharmacotherapy for people with learning disabilities","volume":"7","author":"Einfeld","year":"2004","journal-title":"Advances in Psychiatric Treatment"},{"issue":"1","key":"10.1016\/j.ridd.2013.12.004_bib0070","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00213-011-2194-7","article-title":"A prospective open-label study of aripiprazole in fragile X syndrome","volume":"216","author":"Erickson","year":"2011","journal-title":"Journal of Psychopharmacology"},{"issue":"3","key":"10.1016\/j.ridd.2013.12.004_bib0075","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1089\/cap.2010.0103","article-title":"A retrospective review of the effectiveness of aripiprazole in the treatment of sensory abnormalities in autism","volume":"22","author":"Fung","year":"2012","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"key":"10.1016\/j.ridd.2013.12.004_bib0080","series-title":"ECDEU assessment manual for psychopharmacology","first-page":"217","author":"Guy","year":"1976"},{"key":"10.1016\/j.ridd.2013.12.004_bib0085","series-title":"Abnormal involuntary movement scale (AIMS). ECDEU assessment manual for psychopharmacology","first-page":"534","author":"Guy","year":"1976"},{"issue":"1","key":"10.1016\/j.ridd.2013.12.004_bib0090","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1108\/17530180200800005","article-title":"A qualitative study on the knowledge and views that people with learning disabilities and their carers have of psychotropic medication prescribed for behaviour problems","volume":"2","author":"Hall","year":"2008","journal-title":"Advances in Mental Health and Learning Disabilities"},{"issue":"7","key":"10.1016\/j.ridd.2013.12.004_bib0095","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1017\/S1461145709009948","article-title":"Aripiprazole differentially affects mesolimbic and nigrostriatal dopaminergic transmission: Implications for long-term drug efficacy and low extrapyramidal side-effects","volume":"12","author":"Han","year":"2009","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.ridd.2013.12.004_bib0100","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/19315864.2010.542274","article-title":"Long-term aripiprazole in youth with developmental disabilities including autism","volume":"4","author":"Hellings","year":"2011","journal-title":"Journal of Mental Health Research in Intellectual Disabilities"},{"issue":"2","key":"10.1016\/j.ridd.2013.12.004_bib0105","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/19315864.2012.708100","article-title":"Research for people with intellectual disabilities and mental health problems: A view from the UK","volume":"6","author":"Hemmings","year":"2013","journal-title":"Journal of Mental Health Research in Intellectual Disability"},{"issue":"2","key":"10.1016\/j.ridd.2013.12.004_bib0110","first-page":"211","article-title":"Aripiprazole improves social interaction in Taiwanese children with pervasive developmental disorder","volume":"33","author":"Huang","year":"2010","journal-title":"Chang Gung Medical Journal"},{"issue":"1","key":"10.1016\/j.ridd.2013.12.004_bib0115","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.pnpbp.2011.12.015","article-title":"Switching to aripiprazole in subjects with pervasive developmental disorders showing tolerability issues with risperidone","volume":"37","author":"Ishitobi","year":"2012","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"issue":"3","key":"10.1016\/j.ridd.2013.12.004_bib0120","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00213-012-2723-z","article-title":"Aripiprazole in the treatment of challenging behaviour in adults with autism spectrum disorder","volume":"223","author":"Jordan","year":"2012","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.ridd.2013.12.004_bib0125","first-page":"294","article-title":"Aripiprazole for maladaptive behavior in mental retardation: Case reports","volume":"19","author":"K\u00fclt\u00fcr","year":"2009","journal-title":"Bulletin in Clinical Psychopharmacology"},{"issue":"11","key":"10.1016\/j.ridd.2013.12.004_bib0130","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1097\/CHI.0b013e3181b76658","article-title":"A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder","volume":"48","author":"Marcus","year":"2009","journal-title":"Journal of American Academy of Child and Adolescent Psychiatry"},{"issue":"3","key":"10.1016\/j.ridd.2013.12.004_bib0135","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1089\/cap.2009.0121","article-title":"Aripiprazole in the treatment of irritability in pediatric patients (aged 6\u201317 years) with autistic disorder: Results from a 52-week, open-label study","volume":"21","author":"Marcus","year":"2011","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"9","key":"10.1016\/j.ridd.2013.12.004_bib0140","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.4088\/JCP.09m05933","article-title":"Safety and tolerability of aripiprazole for irritability in pediatric patients with autistic disorder: A 52-week, open-label, multicenter study","volume":"72","author":"Marcus","year":"2011","journal-title":"Journal of Clinical Psychiatry"},{"issue":"6","key":"10.1016\/j.ridd.2013.12.004_bib0145","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2165\/00023210-200923060-00005","article-title":"Aripiprazole monotherapy in children and young adolescents with pervasive developmental disorders: A retrospective study","volume":"23","author":"Masi","year":"2009","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.ridd.2013.12.004_bib0150","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2788.2009.01195.x","article-title":"Overcoming the barriers experienced in conducting a medication trial in adults with aggressive challenging behaviour and intellectual disabilities","volume":"54","author":"Oliver-Africano","year":"2010","journal-title":"Journal of Intellectual Disability Research"},{"issue":"6","key":"10.1016\/j.ridd.2013.12.004_bib0155","first-page":"1533","article-title":"Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder","volume":"124","author":"Owen","year":"2009","journal-title":"Journal of American Academy of Child and Adolescent Psychiatry"},{"issue":"4","key":"10.1016\/j.ridd.2013.12.004_bib0160","doi-asserted-by":"crossref","first-page":"451-s.e33","DOI":"10.1176\/appi.neuropsych.22.4.451-s.e33","article-title":"Aripiprazole treatment for coprophagia in autistic disorder","volume":"22","author":"Pardini","year":"2010","journal-title":"Journal of Neuropsychiatry"},{"key":"10.1016\/j.ridd.2013.12.004_bib0165","series-title":"Psychotropic medication and development disabilities: The international consensus handbook","author":"Reiss","year":"1998"},{"issue":"6","key":"10.1016\/j.ridd.2013.12.004_bib0170","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/00004583-199706000-00023","article-title":"Children's yale-brown obsessive compulsive scale: Reliability and validity","volume":"36","author":"Scahill","year":"1997","journal-title":"Journal of American Academy of Child and Adolescent Psychiatry"},{"issue":"6","key":"10.1016\/j.ridd.2013.12.004_bib0175","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1177\/0269881106067765","article-title":"Aripiprazole use in individuals with intellectual disability and psychotic or behavioural disorders: A case series","volume":"20","author":"Shashtri","year":"2006","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.ridd.2013.12.004_bib0180","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatrica Scandinavica Supplement"},{"issue":"11","key":"10.1016\/j.ridd.2013.12.004_bib0185","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1345\/aph.1D147","article-title":"Aripiprazole in an adult with Asperger disorder","volume":"37","author":"Staller","year":"2003","journal-title":"Annals of Pharmacotherapy"},{"issue":"3","key":"10.1016\/j.ridd.2013.12.004_bib0190","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1089\/cap.2008.093","article-title":"Aripiprazole in pervasive developmental disorder not otherwise specified and Asperger's disorder: A 14-week, prospective, open-label study","volume":"19","author":"Stigler","year":"2009","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"key":"10.1016\/j.ridd.2013.12.004_bib0195","first-page":"S228","article-title":"Medication and parent training in children with pervasive developmental disorders and serious behavior problems: Effectiveness and tolerability of aripiprazole in risperidone nonresponders","volume":"36","author":"Stigler","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.ridd.2013.12.004_bib0200","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1089\/cap.2004.14.455","article-title":"Aripiprazole for maladaptive behavior in pervasive developmental disorders","volume":"14","author":"Stigler","year":"2004","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"key":"10.1016\/j.ridd.2013.12.004_bib0205","series-title":"Psychotropic medication easy read information leaflets","author":"Unwin","year":"2007"},{"issue":"3","key":"10.1016\/j.ridd.2013.12.004_bib0210","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5042\/amhid.2010.0538","article-title":"The use of medication to manage problem behaviours in adults with a learning disability: A national guideline","volume":"4","author":"Unwin","year":"2010","journal-title":"Advances in Mental Health in Intellectual Disabilities"},{"key":"10.1016\/j.ridd.2013.12.004_bib0215","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/j.ridd.2011.07.031","article-title":"Efficacy of atypical antipsychotic medication in the management of behaviour problems in children with intellectual disabilities and borderline intelligence: A systematic review","volume":"32","author":"Unwin","year":"2011","journal-title":"Research in Developmental Disabilities"},{"issue":"5","key":"10.1016\/j.ridd.2013.12.004_bib0220","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1089\/cap.2006.16.549","article-title":"Clinical effects and adverse reactions of off-label use of aripiprazole in children and adolescents with developmental disabilities","volume":"16","author":"Valicenti-McDermott","year":"2006","journal-title":"Journal of Child and Adolescent Psychopharmacology"}],"container-title":["Research in Developmental Disabilities"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891422213005477?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891422213005477?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,7]],"date-time":"2018-10-07T11:56:03Z","timestamp":1538913363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891422213005477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0891422213005477"],"URL":"https:\/\/doi.org\/10.1016\/j.ridd.2013.12.004","relation":{},"ISSN":["0891-4222"],"issn-type":[{"value":"0891-4222","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effectiveness of aripiprazole in the management of problem behaviour in people with intellectual disabilities, developmental disabilities and\/or autistic spectrum disorder \u2013 A systematic review","name":"articletitle","label":"Article Title"},{"value":"Research in Developmental Disabilities","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ridd.2013.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}